Eli Lilly's Good Cholesterol Drug Went Bad. Here's What That Means For Pharma

Albert Einstein never said that the definition of insanity is doing the same thing over and over again and expecting a different result. But whoever did say it was probably talking about a pharmaceutical executive. This morning, Eli Lilly announced that evacetrapib, its experimental drug to raise good cholesterol, failed to prevent [...]